المؤلفون: Ciardiello, D, Chiarazzo, C, Famiglietti, V, Damato, A, Pinto, C, Zampino, M G, Castellano, G, Gervaso, L, Zaniboni, A, Oneda, E, Rapisardi, S, Bordonaro, R, Zichi, C, De Vita, F, Di Maio, M, Parisi, A, Giampieri, R, Berardi, R, Lavacchi, D, Antonuzzo, L, Tamburini, E, Maiorano, B A, Parrella, P, Latiano, T P, Normanno, N, De Stefano, A, Avallone, A, Martini, G, Napolitano, S, Troiani, T, Martinelli, E, Ciardiello, F, Maiello, E

المساهمون: Ciardiello, D, Chiarazzo, C, Famiglietti, V, Damato, A, Pinto, C, Zampino, M G, Castellano, G, Gervaso, L, Zaniboni, A, Oneda, E, Rapisardi, S, Bordonaro, R, Zichi, C, De Vita, F, Di Maio, M, Parisi, A, Giampieri, R, Berardi, R, Lavacchi, D, Antonuzzo, L, Tamburini, E, Maiorano, B A, Parrella, P, Latiano, T P, Normanno, N, De Stefano, A, Avallone, A, Martini, G, Napolitano, S, Troiani, T, Martinelli, E, Ciardiello, F, Maiello, E

مصطلحات موضوعية: KRASG12C mutation, chemotherapy, first line treatment, mCRC, real-world data

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35994791; info:eu-repo/semantics/altIdentifier/wos/WOS:000861347400014; volume:7; issue:5; firstpage:1; lastpage:7; numberofpages:7; journal:ESMO OPEN; https://hdl.handle.net/2318/1887434Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85136240173; https://www.esmoopen.com/article/S2059-7029Test(22)00195-8/fulltext

الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100567Test
https://hdl.handle.net/2318/1887434Test
https://www.esmoopen.com/article/S2059-7029Test(22)00195-8/fulltext

المؤلفون: Capasso A., Benigni A., Capitanio U., Danesh F. R., Di Marzo V., Gesualdo L., Grandaliano G., Jaimes E. A., Malyszko J., Perazella M. A., Qian Q., Ronco P., Rosner M. H., Trepiccione F., Viggiano D., Zoccali C., Capasso G., Akitaka A., Alahoti A., Alexander T. R., Altucci L., Amer H., Barone V., Biancone L., Bonventre J. V., Camussi G., Ciardiello F., Caraglia M., Carteni G., Cervantes A., Citterio F., Cosmai L., Daniele B., D'Errico A., De Vita F., Ereditato A., Falco G., Fouque D., Franco R., Gallieni M., Gambaro G., Kuo C., Launay-Vacher V., Maiello E., Mallamaci F., Malysxko J., Marino G., Martinelli E., Matarese G., Matsubara T., Messa P., Messina C., Mirone V., Morgillo F., Costa A. N., Orditura M., Pani A., Perna A., Pisano C., Pitts T., Porta C., Procopio G., Remuzzi G., Russo D., Siu L. L., Stadler W., Troiani T., Weisz A., Wiecek A., Xiaoqiang D., Zecchino O.

المساهمون: A. Capasso, A. Benigni, U. Capitanio, F.R. Danesh, V. Di Marzo, L. Gesualdo, G. Grandaliano, E.A. Jaime, J. Malyszko, M.A. Perazella, Q. Qian, P. Ronco, M.H. Rosner, F. Trepiccione, D. Viggiano, C. Zoccali, G. Capasso, A. Akitaka, A. Alahoti, T.R. Alexander, L. Altucci, H. Amer, V. Barone, L. Biancone, J.V. Bonventre, G. Camussi, F. Ciardiello, M. Caraglia, G. Carteni, A. Cervante, F. Citterio, L. Cosmai, B. Daniele, A. D'Errico, F. De Vita, A. Ereditato, G. Falco, D. Fouque, R. Franco, M. Gallieni, G. Gambaro, C. Kuo, V. Launay-Vacher, E. Maiello, F. Mallamaci, J. Malysxko, G. Marino, E. Martinelli, G. Matarese, T. Matsubara, P. Messa, C. Messina, V. Mirone, F. Morgillo, A.N. Costa, M. Orditura, A. Pani, A. Perna, C. Pisano, T. Pitt, C. Porta, G. Procopio, G. Remuzzi, D. Russo, L.L. Siu, W. Stadler, T. Troiani, A. Weisz, A. Wiecek, D. Xiaoqiang, O. Zecchino

مصطلحات موضوعية: acute kidney injury, cancer, chemotherapy, chronic kidney disease, nephrotoxicity, renal cell carcinoma, Settore MED/14 - Nefrologia, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31445584; info:eu-repo/semantics/altIdentifier/wos/WOS:000482187800009; International Conference on Onco-Nephrology; volume:96; issue:3; firstpage:555; lastpage:567; numberofpages:13; journal:KIDNEY INTERNATIONAL; http://hdl.handle.net/2434/674370Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070632078

الإتاحة: https://doi.org/10.1016/j.kint.2019.04.043Test
http://hdl.handle.net/2434/674370Test

المؤلفون: Viscardi G., Tralongo A. C., Massari F., Lambertini M., Mollica V., Rizzo A., Comito F., Di Liello R., Alfieri S., Imbimbo M., Della Corte C. M., Morgillo F., Simeon V., Lo Russo G., Proto C., Prelaj A., De Toma A., Galli G., Signorelli D., Ciardiello F., Remon J., Chaput N., Besse B., de Braud F., Garassino M. C., Torri V., Cinquini M., Ferrara R.

المساهمون: Viscardi, G., Tralongo, A. C., Massari, F., Lambertini, M., Mollica, V., Rizzo, A., Comito, F., Di Liello, R., Alfieri, S., Imbimbo, M., Della Corte, C. M., Morgillo, F., Simeon, V., Lo Russo, G., Proto, C., Prelaj, A., De Toma, A., Galli, G., Signorelli, D., Ciardiello, F., Remon, J., Chaput, N., Besse, B., de Braud, F., Garassino, M. C., Torri, V., Cinquini, M., Ferrara, R.

مصطلحات موضوعية: Breast cancer, Chemotherapy, Early mortality, Gastrointestinal cancer, Genitourinary cancer, Immune checkpoint blocker, Immunotherapy, Lung cancer, Melanoma, Meta-analysis

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000907032000002; volume:177; firstpage:175; lastpage:185; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11591/483618Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85141288757

الإتاحة: https://doi.org/10.1016/j.ejca.2022.09.031Test
https://hdl.handle.net/11591/483618Test

المؤلفون: Vicidomini G., Della Corte C. M., Noro A., Di Liello R., Cappabianca S., Fiorelli A., Nardone V., Messina G., Viscardi G., Sangiovanni A., Monti R., Accardo M., Morgillo F., Ciardiello F., Franco R., Santini M.

المساهمون: Vicidomini, G., Della Corte, C. M., Noro, A., Di Liello, R., Cappabianca, S., Fiorelli, A., Nardone, V., Messina, G., Viscardi, G., Sangiovanni, A., Monti, R., Accardo, M., Morgillo, F., Ciardiello, F., Franco, R., Santini, M.

مصطلحات موضوعية: Chemotherapy, Mesothelioma, Radiation therapy, Statistic, Surgery technique, Survival analysis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35008306; info:eu-repo/semantics/altIdentifier/wos/WOS:000741409500001; volume:14; issue:1; firstpage:142; journal:CANCERS; http://hdl.handle.net/11591/462634Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121834599

الإتاحة: https://doi.org/10.3390/cancers14010142Test
http://hdl.handle.net/11591/462634Test

المؤلفون: Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C, TORCH Investigators, Calabro' L

المساهمون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigator, Calabro', L

مصطلحات موضوعية: Advanced non-small-cell lung cancer, Chemotherapy, EGFR, Erlotinib, First-line treatment, Health-related quality of life, Randomized trial

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11392/2492624Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842; https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext; https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

الإتاحة: https://doi.org/10.1097/JTO.0b013e318275b327Test
http://hdl.handle.net/11392/2492624Test
https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext
https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

المؤلفون: De Placido S., Gallo C., De Laurentiis M., Bisagni G., Arpino G., Sarobba M. G., Riccardi F., Russo A., Del Mastro L., Cogoni A. A., Cognetti F., Gori S., Foglietta J., Frassoldati A., Amoroso D., Laudadio L., Moscetti L., Montemurro F., Verusio C., Bernardo A., Lorusso V., Gravina A., Moretti G., Lauria R., Lai A., Mocerino C., Rizzo S., Nuzzo F., Carlini P., Perrone F., Accurso A., Agostara B., Aieta M., Alabiso O., Alicicco M. G., Amadori D., Amaducci L., Amiconi G., Antuzzi G., Ardine M., Ardizzoia A., Aversa C., Badalamenti G., Barni S., Basurto C., Berardi R., Bergamasco C., Bidoli P., Bighin C., Biondi E., Boni C., Borgonovo K., Botta M., Bravi S., Bruzzi P., Buono G., Butera A., Caldara A., Candeloro G., Cappelletti C., Cardalesi C., Carfora E., Cariello A., Carrozza F., Carteni G., Caruso M., Casadei V., Casanova C., Castori L., Cavanna L., Cavazzini G., Cazzaniga M., Chilelli M., Chiodini P., Chiorrini S., Ciardiello F., Ciccarese M., Cinieri S., Clerico M., Coccaro M., Comande M., Corbo C., Cortino G., Cusenza S., Daniele G., D'arco A. M., D'auria G., Dazzi C., De Angelis C., de Braud F., De Feo G., De Matteis MA., De Tursi M., Di Blasio A., di Lucca G., Di Lullo L., Di Rella F., Di Renzo G., Di Stefano P., Di Stefano A., Diana A., Donati S., Fabbri A., Fabi A., Faedi M., Farina G., Farris A., Febbraro A., Fedele P., Federico P., Ferrau F., Ferretti G., Ferro A., Floriani I., Forcignano R., Forciniti S., Forestieri V., Fornari G., Frisinghelli M., Fusco V., Gallizzi G., Galvano A., Gambardella A., Gambi A., Gebbia V., Gervasi E., Ghilardi M., Giacobino A., Giardina G., Giotta F., Giraudi S., Giuliano M., Grassadonia A., Grasso D., Grosso F., Guizzaro L., Incoronato P., Incorvaia L., Iodice G., La Verde N., Labonia V., Landi G., Latorre A., Leonardi V., Levaggi A., Limite G., Lina Bascialla L., Livi L., Maiello E., Mandelli D., Marcon I., Menon D., Montedoro M., Moraca L., Moretti A., Morritti M. G., Morselli P., Mura A., Mura S., Musacchio M., Muzio A., Natale D., Natoli C., Nigro C., Nistico C., Nuzzo A., Orditura M., Orlando L., Pacilio C., Palumbo G., Palumbo R., Pasini F., Paterno E., Pazzola A., Pelliccioni S., Pensabene M., Perroni D., Pesenti Gritti A., Petrelli F., Piccirillo M. C., Pinotti G., Pogliani C., Poli D., Prader S., Recchia F., Rizzi D., Romano C., Rossello R., Rossini C., Salvucci G., Sanna V., Santini A., Saracchini S., Savastano C., Scambia G., Schettini F., Schiavone P., Schirone A., Seles E., Signoriello S., Signoriello G., Silva R. R., Silvestri A., Simeon V., Spagnoletti I., Tamberi S., Teragni C., Thalmann V., Thomas R., Thomas G., Tienghi A., Tinari N., Tinessa V., Tomei F., Tonini G., Torri V., Traficante D., Tudini M., Turazza M., Vignoli R., Vitale M. G., Zacchia A., Zagarese P., Zanni A., Zavallone L., Zavettieri M., Zoboli A.

المساهمون: De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A., Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Carteni, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'Arco, A. M., D'Auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, Ma., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P.

مصطلحات موضوعية: Aged, Anastrozole, Androstadiene, Antineoplastic Combined Chemotherapy Protocol, Aromatase Inhibitor, Breast Neoplasm, Chemotherapy, Adjuvant, Disease-Free Survival, Drug Administration Schedule, Female, Human, Letrozole, Middle Aged, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Tamoxifen

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000428790400036; volume:19; issue:4; firstpage:474; lastpage:485; numberofpages:12; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11588/789500Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042358192; http://www.journals.elsevier.com/the-lancet-oncologyTest/

الإتاحة: https://doi.org/10.1016/S1470-2045Test(18)30116-5
http://hdl.handle.net/11588/789500Test
http://www.journals.elsevier.com/the-lancet-oncologyTest/

المؤلفون: Orditura M., Gravina A., Riccardi F., Diana A., Mocerino C., Leopaldi L., Fabozzi A., Giordano G., Nettuno R., Incoronato P., Barzelloni M. L., Caputo R., Pisano A., Grimaldi G., Genua G., Montesarchio V., Barbato E., Iodice G., Lieto E., Procaccini E., Mabilia R., Febbraro A., Laurentiis M. D., Ciardiello F.

المساهمون: Orditura, M., Gravina, A., Riccardi, F., Diana, A., Mocerino, C., Leopaldi, L., Fabozzi, A., Giordano, G., Nettuno, R., Incoronato, P., Barzelloni, M. L., Caputo, R., Pisano, A., Grimaldi, G., Genua, G., Montesarchio, V., Barbato, E., Iodice, G., Lieto, E., Procaccini, E., Mabilia, R., Febbraro, A., Laurentiis, M. D., Ciardiello, F.

مصطلحات موضوعية: advanced breast cancer, chemotherapy, eribulin, real-world population

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28761747; info:eu-repo/semantics/altIdentifier/wos/WOS:000408040300011; volume:2; issue:2; journal:ESMO OPEN; http://hdl.handle.net/11369/393425Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85052689515

الإتاحة: https://doi.org/10.1136/esmoopen-2017-000176Test
http://hdl.handle.net/11369/393425Test

المؤلفون: Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AMJ, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJM, van den Berg PM, Zielinski CC, Chittazhathu Kurian Kuruvilla Y, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF, EMPHASIS-lung Collaborative Group

المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life, Peters, S, Stahel, Ra, Dafni, U, Aix, Sp, Massutí, B, Gautschi, O, Coate, L, López Martín, A, Van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Noguera, Jg, Curioni Fontecedro, A, Rauch, D, Mark, Mt, Cuffe, S, Biesma, B, Van Henten, Am, Vidal, Ój, Sanchez, Rp, Villa Guzmán, Jc, Martin, Rc, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, Fortunato, De Hosson, S, Pieterman, R, Groen, Hj, Van Den Berg, Pm, Zielinski, Cc, Kuruvilla, Yc, Gasca Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, Ef, EMPHASIS lung collaborative, Group

المصدر: JOURNAL OF THORACIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Journal of Thoracic Oncology, 12(4), 752-762. International Association for the Study of Lung Cancer
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Journal of Thoracic Oncology, 12(4), 752-762. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Docetaxel, NSCLC, THERAPY, Squamous, Cohort Studies, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 3RD-LINE, Antineoplastic Combined Chemotherapy Protocols, VeriStrat, 030212 general & internal medicine, Erlotinib Hydrochloride, ETOP, Prognosis, Survival Rate, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, Veristrat, 2ND-LINE TREATMENT, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, TYROSINE KINASE INHIBITORS, Journal Article, Humans, Lung cancer, COMBINATION, Survival rate, neoplasms, METAANALYSIS, Aged, Neoplasm Staging, Platinum, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, business, GROWTH-FACTOR RECEPTOR, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1d367d8bc33b24edc27d000909d5bdTest
https://pubmed.ncbi.nlm.nih.gov/28343541Test

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test

المؤلفون: Gridelli C, Novello S, Zilembo N, Luciani A, Favaretto A. G, Marinis F. D, Genestreti G, Grossi F, Caffo O, Ferrau F, Cruciani G, Brandes A. A, Galetta D, Barni S, Fasola G, Cerea G, Ferrari S, Iannacone C, Ciardiello F., CRINO', Lucio

المساهمون: Gridelli, C, Novello, S, Zilembo, N, Luciani, A, Favaretto, A. G., Marinis, F. D., Genestreti, G, Crino', Lucio, Grossi, F, Caffo, O, Ferrau, F, Cruciani, G, Brandes, A. A., Galetta, D, Barni, S, Fasola, G, Cerea, G, Ferrari, S, Iannacone, C, Ciardiello, F.

مصطلحات موضوعية: 2ND-LINE TREATMENT, KINASE INHIBITOR, DOUBLE-BLIND, METAANALYSIS, TRIAL, CHEMOTHERAPY, DOCETAXEL, THERAPY

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000334627500021; volume:9; issue:5; firstpage:733; lastpage:737; numberofpages:5; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11391/1333117Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84899049029

الإتاحة: https://doi.org/10.1097/JTO.0000000000000120Test
http://hdl.handle.net/11391/1333117Test